336 related articles for article (PubMed ID: 18635538)
1. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.
Kubota T; Matsuoka M; Chang TH; Tailor P; Sasaki T; Tashiro M; Kato A; Ozato K
J Biol Chem; 2008 Sep; 283(37):25660-25670. PubMed ID: 18635538
[TBL] [Abstract][Full Text] [Related]
2. A protective role of IRF3 and IRF7 signalling downstream TLRs in the development of vein graft disease via type I interferons.
Simons KH; Peters HAB; Jukema JW; de Vries MR; Quax PHA
J Intern Med; 2017 Dec; 282(6):522-536. PubMed ID: 28857295
[TBL] [Abstract][Full Text] [Related]
3. SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response.
Crowl JT; Stetson DB
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):6798-6803. PubMed ID: 29891701
[TBL] [Abstract][Full Text] [Related]
4. Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection.
Fang L; Choudhary S; Tian B; Boldogh I; Yang C; Ivanciuc T; Ma Y; Garofalo RP; Brasier AR
J Virol; 2015 Mar; 89(5):2628-42. PubMed ID: 25520509
[TBL] [Abstract][Full Text] [Related]
5. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
6. ERVs-TLR3-IRF axis is linked to myelodysplastic syndrome pathogenesis.
de Oliveira RTG; Cordeiro JVA; Vitoriano BF; de Lima Melo MM; Sampaio LR; de Paula Borges D; Magalhães SMM; Pinheiro RF
Med Oncol; 2021 Feb; 38(3):27. PubMed ID: 33594613
[TBL] [Abstract][Full Text] [Related]
7. Seneca Valley Virus 3C
Xue Q; Liu H; Zhu Z; Yang F; Ma L; Cai X; Xue Q; Zheng H
Virology; 2018 May; 518():1-7. PubMed ID: 29427864
[TBL] [Abstract][Full Text] [Related]
8. Deletion of Irf3 and Irf7 Genes in Mice Results in Altered Interferon Pathway Activation and Granulocyte-Dominated Inflammatory Responses to Influenza A Infection.
Hatesuer B; Hoang HT; Riese P; Trittel S; Gerhauser I; Elbahesh H; Geffers R; Wilk E; Schughart K
J Innate Immun; 2017; 9(2):145-161. PubMed ID: 27811478
[TBL] [Abstract][Full Text] [Related]
9. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7.
Liang Q; Deng H; Li X; Wu X; Tang Q; Chang TH; Peng H; Rauscher FJ; Ozato K; Zhu F
J Immunol; 2011 Nov; 187(9):4754-63. PubMed ID: 21940674
[TBL] [Abstract][Full Text] [Related]
10. IRF7 Is Required for the Second Phase Interferon Induction during Influenza Virus Infection in Human Lung Epithelia.
Wu W; Zhang W; Tian L; Brown BR; Walters MS; Metcalf JP
Viruses; 2020 Mar; 12(4):. PubMed ID: 32235406
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Interferon Regulatory Factor 7 in Nicotine's Suppression of Antiviral Immune Responses.
Han H; Huang W; Du W; Shen Q; Yang Z; Li MD; Chang SL
J Neuroimmune Pharmacol; 2019 Dec; 14(4):551-564. PubMed ID: 31154625
[TBL] [Abstract][Full Text] [Related]
12. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
[TBL] [Abstract][Full Text] [Related]
13. The Role of Optineurin in Antiviral Type I Interferon Production.
Outlioua A; Pourcelot M; Arnoult D
Front Immunol; 2018; 9():853. PubMed ID: 29755463
[TBL] [Abstract][Full Text] [Related]
14. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of IKK alpha-mediated activation of IRF3/7 by NIK.
Wang RP; Zhang M; Li Y; Diao FC; Chen D; Zhai Z; Shu HB
Mol Immunol; 2008 Apr; 45(7):1926-34. PubMed ID: 18068231
[TBL] [Abstract][Full Text] [Related]
16. SAMHD1 impairs type I interferon induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection.
Espada CE; Sari L; Cahill MP; Yang H; Phillips S; Martinez N; Kenney AD; Yount JS; Xiong Y; Lin MM; Wu L
J Biol Chem; 2023 Jul; 299(7):104925. PubMed ID: 37328105
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling.
Ning S; Huye LE; Pagano JS
J Biol Chem; 2005 Apr; 280(13):12262-70. PubMed ID: 15664995
[TBL] [Abstract][Full Text] [Related]
18. Deactylation by SIRT1 enables liquid-liquid phase separation of IRF3/IRF7 in innate antiviral immunity.
Qin Z; Fang X; Sun W; Ma Z; Dai T; Wang S; Zong Z; Huang H; Ru H; Lu H; Yang B; Lin S; Zhou F; Zhang L
Nat Immunol; 2022 Aug; 23(8):1193-1207. PubMed ID: 35879450
[TBL] [Abstract][Full Text] [Related]
19. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
Oganesyan G; Saha SK; Guo B; He JQ; Shahangian A; Zarnegar B; Perry A; Cheng G
Nature; 2006 Jan; 439(7073):208-11. PubMed ID: 16306936
[TBL] [Abstract][Full Text] [Related]
20. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia.
Crotta S; Davidson S; Mahlakoiv T; Desmet CJ; Buckwalter MR; Albert ML; Staeheli P; Wack A
PLoS Pathog; 2013; 9(11):e1003773. PubMed ID: 24278020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
